These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4201792)

  • 1. Letter: Stimulant drugs for problem children.
    N Engl J Med; 1973 Dec; 289(25):1375-6. PubMed ID: 4201792
    [No Abstract]   [Full Text] [Related]  

  • 2. Treating problem children with stimulant drugs.
    Sroufe LA; Stewart MA
    N Engl J Med; 1973 Aug; 289(8):407-13. PubMed ID: 4146358
    [No Abstract]   [Full Text] [Related]  

  • 3. Mood-altering drugs and hyperkinetic children.
    Erenberg G
    Pediatrics; 1972 Feb; 49(2):308-11. PubMed ID: 5059542
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence and efficacy of stimulant drug use with mentally retarded children and youth.
    Gadow KD
    Psychopharmacol Bull; 1985; 21(2):291-303. PubMed ID: 2860693
    [No Abstract]   [Full Text] [Related]  

  • 5. Drugs for the hyperactive child.
    DiPalma JR
    RN; 1972 May; 35(5):61-9. PubMed ID: 4483480
    [No Abstract]   [Full Text] [Related]  

  • 6. Review of stimulant drugs in learning and behavior disorders.
    Conners CK
    Psychopharmacol Bull; 1971 Jul; 7(3):39-40. PubMed ID: 5117857
    [No Abstract]   [Full Text] [Related]  

  • 7. Levoamphetamine and dextroamphetamine: differential effect on aggression and hyperkinesis in children and dogs.
    Arnold LE; Kirilcuk V; Corson SA; Corson EO
    Am J Psychiatry; 1973 Feb; 130(2):165-70. PubMed ID: 4568123
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of dextro-amphetamine and racemic-amphetamine in the treatment of the hyperkinetic syndrome or minimal brain dysfunction.
    Gross MD
    Dis Nerv Syst; 1976 Jan; 37(1):14-6. PubMed ID: 1106966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of hyperactivity and attention deficit with amphetamine. Experience with five adult prisoners].
    Stovner AM; Wyller TB; Skulberg A; Os L; Korsmo G
    Tidsskr Nor Laegeforen; 1996 Jun; 116(17):2002-5. PubMed ID: 8766640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug therapy in minimal brain dysfunction: a commentary.
    Erenberg G
    J Pediatr; 1972 Aug; 81(2):359-65. PubMed ID: 4557602
    [No Abstract]   [Full Text] [Related]  

  • 11. NTP-CERHR monograph on the potential human reproductive and developmental effects of amphetamines.
    National Toxicology Program
    NTP CERHR MON; 2005 Jul; (16):vii-III1. PubMed ID: 16130031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symposium: behavior modification by drugs. 3. The clinical use of stimulant drugs in children.
    Eisenberg L
    Pediatrics; 1972 May; 49(5):709-15. PubMed ID: 4504174
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety of stimulant treatment in attention deficit hyperactivity disorder: Part I.
    Merkel RL; Kuchibhatla A
    Expert Opin Drug Saf; 2009 Nov; 8(6):655-68. PubMed ID: 19785509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stimulants in the treatment of hyperkinetic behavior disorders].
    Barkai A
    Harefuah; 1971 Mar; 80(6):298-302. PubMed ID: 4946564
    [No Abstract]   [Full Text] [Related]  

  • 15. Amphetamine-type drugs for hyperactive children.
    Med Lett Drugs Ther; 1972 Mar; 14(7):21-3. PubMed ID: 4648553
    [No Abstract]   [Full Text] [Related]  

  • 16. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulant therapy in attention deficit/hyperactivity disorder.
    Baldwin RL
    J Ark Med Soc; 2003 Dec; 100(6):203-6. PubMed ID: 14661403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of stimulant medication with children.
    Phillips S
    J Dev Behav Pediatr; 1989 Dec; 10(6):319-20. PubMed ID: 2600187
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral medications for minimal brain dysfunction in children.
    Green RP; Scales SM; Rosser PL
    J Natl Med Assoc; 1973 Mar; 65(2):157-60. PubMed ID: 4691677
    [No Abstract]   [Full Text] [Related]  

  • 20. Reduced salivary cortisol in children with comorbid Attention deficit hyperactivity disorder and oppositional defiant disorder.
    Kariyawasam SH; Zaw F; Handley SL
    Neuro Endocrinol Lett; 2002 Feb; 23(1):45-8. PubMed ID: 11880861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.